Insulin secretion in liver transplant recipients following conversion to a prolonged release tacrolimus formulation.

导出 LinkOut

翻译打印收藏纠错

作者： David,Peretz ^[1] ; Nabiha,Faisal ^[2] ; Julia,Uhanova ^[1] ; Isanne,Schacter ^[2] ; Diane,McAlpine ^[1] ; Cori,Knowles ^[2] ; Gerald Y,Minuk ^[2]

作者单位： Section of Hepatology. ^[1] Section of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. ^[2] Paladin Labs Inc., Saint-Laurent, Quebec, Canada. ^[3]

关键词 PA envarsus formulations insulin secretion tacrolimus

DOI 10.3138/canlivj-2022-0046

PMID 38020189

发布时间 2023-12-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Canadian liver journal

2023年6卷3期

353-357页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Insulin secretion in liver transplant recipients following conversion to a prolonged release tacrolimus formulation.

Canadian liver journal

相似文献

Canadian liver journal

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Insulin secretion in liver transplant recipients following conversion to a prolonged release tacrolimus formulation.

Canadian liver journal

相似文献

Canadian liver journal

相关期刊

检索历史清除